Physician profile
Muhammad Rafique
NPI 1568823912
$854.76
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $130 · 2022: $57.06 · 2023: $294 · 2024: $115 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $148.67 | 2021-2022 | |
| Livanova USA, INC. | $131.76 | 2023 | Lifesparc |
| Boston Scientific Corporation | $114.56 | 2022-2025 | General - Therapies, Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $101.42 | 2019-2024 | Farxiga |
| Abiomed | $98.11 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $42.64 | 2022-2025 | |
| Amgen INC. | $38.94 | 2019 | |
| Edwards Lifesciences Corporation | $32.96 | 2025 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $26.18 | 2024 | |
| Sanofi-Aventis U.S. LLC | $24.35 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.91 | 2023 | Lifevest |
| Bracco Diagnostics INC. | $19.62 | 2023 | |
| Lantheus Medical Imaging, INC. | $15.37 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $14.43 | 2019 | |
| Pfizer INC. | $12.58 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Rafique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.